SONA Asset Management (US)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-108,000
Closed -$17.2M 147
2023
Q1
$17.2M Buy
108,000
+80,000
+286% +$12.2M 3.7% 8
2022
Q4
$4.53M Buy
+28,000
New +$4.29M 1.3% 7

Other funds holding ABBV

SONA Asset Management (US)'s ABBV Position: Q2 2023 in Review

SONA Asset Management (US) sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 108,000 shares — an estimated $17.2M sold.

SONA Asset Management (US) first reported a position in ABBV in Q4 2022 and held it in 2 quarters. The position peaked at $17.2M in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • SONA Asset Management (US) reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • SONA Asset Management (US) sold 108,000 AbbVie shares in Q2 2023, an estimated $17.2M.
  • SONA Asset Management (US) first reported a position in AbbVie in Q4 2022 and held it in 2 quarters.
  • SONA Asset Management (US)'s AbbVie position peaked at $17.2M in Q1 2023.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on SONA Asset Management (US)'s 13F filing for Q2 2023, filed 11 Aug 2023.